or extracellular signal-regulated kinases (ERKs) participate in various intracellular signaling pathways that respond to extracellular stimuli in a variety of cell types (1) (2) (3) (4) (5) (6) . In mammalian cells, there are at least four distinct intracellular signaling pathways identified to date: MAPK/ERK (7-9), c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) (10 -15) , p38 (16 -18) , and ERK5 (19) . The ERK pathway is known to be involved in growth factor-mediated activation and differentiation in several cells types (1, 7, 9) . It is activated by various extracellular signals, including mitogenic growth factors such as insulin, epidermal growth factor, and phorbol esters (2, 8, 9, 20) . The JNK pathway, also referred to as the SAPK pathway, is potently activated in response to a variety of environmental stress stimuli such as UV light, osmotic and heat shock, and proinflammatory cytokines (9 -14) . The JNK can also be partially activated by some mitogens such as epidermal growth factor and phorbol esters (21) . Recently, an additional kinase, p38 kinase, which has significant homology to the Saccharomyces cerevisiae HOG1 kinase, was identified. The mammalian p38 kinase is activated by high osmolarity, lipopolysaccharide, tumor necrosis factor ␣, and interleukin-1 (16 -18) .
The phosphorylation cascades of these kinase pathways consist of MAPK kinase kinases (MAPKKK) or MEK kinases (MEKK), MAPK kinases (MKK or MEK), and MAPK/ERK (3) . MAPKKK/MEKK phosphorylates and activates its downstream protein kinase (MKK/MEK, a dual-specific protein kinase), which in turn phosphorylates at both tyrosine and threonine residues of MAPK or ERK (2, 3) . The kinases of these signaling cascades are highly conserved, and homologues exist in yeast, Drosophila, and mammalian cells.
Several mammalian MAPKKKs/MEKKs have been identified to date, including c-Raf (22) (23) (24) , c-Mos (25) (26) (27) , and MEKK1, -2, and -3 (28, 29) . c-Raf and c-Mos activate the classical MAPK/ERK pathway. MEKK1 and -2, which are related to the budding yeast STE11 and BYR2, preferentially activate the JNK/SAPK kinase pathway (30 -32) . MEKK3, when overexpressed in transfected cells, appears to preferentially activate the MAPK/ERK pathway (29) . The MAPKKK/ MEKK kinase involved in the activation of the p38 kinase pathway has not been clearly identified. Recent studies suggested that the transforming growth factor-␤-activated kinase TAK1 (33), a kinase distantly related to Raf and MEKK1, can activate p38 kinase (34) .
We report here the isolation of a novel human protein kinase, which we will refer to as MAPKKK5, whose kinase domain shows significant sequence homology with yeast and mammalian MAPKKK/MEKK. Expression of MAPKKK5 potently activates the JNK/SAPK in transfected COS cells. Furthermore, MAPKKK5 phosphorylates and activates MKK4 in vitro; thus, MAPKKK5 may be an upstream activator of JNK that functions through direct phosphorylation of MKK4.
EXPERIMENTAL PROCEDURES
cDNA Library Screening and Cloning of MAPKKK5-Degenerate oligonucleotide primers were designed to the conserved regions of the yeast BYR2 and STE11 and mouse MEKK1 and were used in a polym-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The erase chain reaction (PCR) using the human spleen cDNA as templates. The sequences of the primers were: 5Ј-AT(CT)(AG)T(ACGT)CA(C-T)(AC)G(ACGT)GA(CT)(AG)T(ACGT)AA(AG)GG-3Ј (sense) and 5Ј-(ACGT) (GT) (ACT) (ACGT) AC(CT) TC (ACGT) GG (ACGT)G(CT)CAT-3Ј (antisense) corresponding to the conserved amino acids in the kinase subdomains VI and VIII. The PCR reactions were run for 35 cycles (94°C for 30 s, 48°C for 30 s, and 72°C for 1 min) followed by an extension at 72°C for 6 min. DNA segments of approximately 180 base pairs were isolated and cloned into a TA cloning vector (Invitrogen, San Diego, CA) and sequenced. A ZAPII phage cDNA library was constructed with mRNA from human macrophages cultured for 7 days in the presence of calcitriol. Replicate filters were prehybridized for 2 h at 42°C in 5 ϫ standard saline citrate (SSC), 1 ϫ Denhardt's solution containing 100 g/ml salmon sperm DNA, 50% formamide, 0.1% SDS and were hybridized overnight in the same solution to the 180-base pair probe labeled with [␣-
32 P]dCTP. After hybridization, the filters were washed twice (2 ϫ 30 min) in 0.1 ϫ SSC, 0.1% SDS at 55°C. Positive clones were isolated and sequenced on both strands.
Northern Blot Analysis of MAPKKK5-Filters containing poly(A)
ϩ RNA (2 g/lane) from various tissues were purchased from Clontech (Palo Alto, CA). Filters were probed with a MAPKKK5 probe corresponding to the 3Ј end of the coding region of MAPKKK5. Hybridization was performed at 68°C in Express Hybridization Buffer (Clontech) followed by three washings in 0.1% ϫ SSC, 0.1% SDS at 55°C. Blots were exposed for 24 h at Ϫ70°C. Plasmid Construction and Expression-Oligonucleotide primers were used in PCR reactions to amplify a 1371-base pair DNA fragment encoding amino acids 648-1105 containing all of the kinase subdomains (referred to as ⌬MAPKKK5) using MAPKKK5 cDNA as a template. The primers added a flag epitope tag sequence or an HA epitope tag sequence at the 5Ј end. The PCR product was cloned into the mammalian expression vector pCR3.1 vector (Invitrogen). A longer version of MAP-KKK5 (amino acids 156-1105) was generated by subcloning the BstXI/ XbaI fragment (2919 base pairs) into the expression vector pcDNA3 (Invitrogen). A catalytically inactive mutant of MAPKKK5 was created by substituting lysine 709 with a glutamic acid (K709E mutant) by site-directed mutagenesis using the overlapping PCR method as described (35) .
COS and 293 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 units/ml penicillin, and 50 g/ml streptomycin. For transfection, 2 ϫ 10 6 cells were plated onto 100-mm dishes 16 -20 h before transfection. DNA (5.0 g) was transfected using LipofectAMINE (Life Technologies, Inc.) Transfected cells were incubated for 5 h in serum-free DMEM, further incubated in DMEM with 10% fetal calf serum, and harvested at 48 h after transfection by dislodging into lysis buffer (20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.5% Igepal, 150 mM NaCl, 20 mM NaF, 0.2 mM Na 3 VO 4 , 1 mM EDTA, and 1 mM EGTA). The lysates were then sedimented (15,000 ϫ g for 60 min) to remove insoluble macromolecules.
JNK/SAPK Kinase Activity Assay-Cells cotransfected with MAP-KKK5 and HA-tagged JNK1 plasmid (kindly provided by J. Woodgett) were lysed as described above. Supernatants containing 200 g of protein were immunoprecipitated with monoclonal antibody 12CA5 to the HA epitope (Berkeley Antibody Co., Richmond, CA) and protein A-Sepharose CL-4B beads (Sigma). Beads were washed 3 times with lysis buffer and once with kinase buffer (25 mM HEPES (pH 7.4), 25 mM ␤-glycerophosphate, 25 mM MgCl 2 , 25 mM dithiothreitol, and 0.1 mM Na 3 VO 4 ) and resuspended in 40 l of the same kinase buffer. The beads were then incubated with human c-Jun (1-169)-GST and 2 l of [␥-32 P]ATP at 30°C for 30 min. Reaction mixtures were then resuspended in 2 ϫ sample buffer (125 mM Tris, 6% SDS, and 20% glycerol) and boiled at 100°C for 3 min. Phosphorylated proteins were analyzed by SDS-PAGE, after which the gels were dried and exposed to radiographic film.
MAPK Kinase Assay-Lysates from cells transfected with 5 g of HA epitope-tagged MAPKKK5 plasmid DNA plus flag epitope-tagged ERK2 plasmid DNA were prepared and incubated with M2 mAb (Sigma) to the flag epitope and protein A-Sepharose to immunoprecipitate ERK2. Immunoprecipitates were washed 3 times with lysis buffer and once with kinase buffer (25 mM HEPES (pH 7.4), 25 mM ␤-glycerophosphate, 25 mM MgCl 2 , 25 mM dithiothreitol, and 0.1 mM Na 3 VO 4 ) and resuspended in 35 l of kinase buffer. Thereafter, 1 g of recombinant Phas-I protein was added along with 2 l of [␥-
32 P]ATP and incubated at 30°C for 10 min. Reactions were stopped by adding 2 ϫ sample buffer and boiling at 100°C for 3 min. Phosphorylated proteins were resolved by SDS-PAGE.
In Vitro Protein Kinase Assays-Cell lysates were immunoprecipitated with M2 mAb and protein A-Sepharose CL-4B beads as described above. The immunoprecipitated kinases were resuspended in 40 l of reaction buffer (20 mM MOPS (pH 7.2), 25 mM ␤-glycerol phosphate, 5 mM EGTA, 1 mM Na 3 VO 4 , and 1 mM dithiothreitol). Thereafter, 10 l of reaction buffer containing 1 g of a kinase-inactive GST fusion protein of MKK4/SEK1 (Upstate Biotechnology, Inc., Lake Placid, NY), 25 mM MgCl 2 , and 500 M ATP along with 10 Ci of [␥-
32 P]ATP were added and incubated at 30°C for 30 min. Reactions were stopped by adding 2 ϫ sample buffer and boiling at 100°C for 3 min. Phosphorylated proteins were resolved by SDS-PAGE.
In Vitro Coupled Assay for the Activation of JNK/SAPK-MAPKKK5 was immunoprecipitated as described for the in vitro protein kinase assay and resuspended in the same buffer. Thereafter, 10 l of reaction buffer containing 1 g of the mouse MKK4 recombinant protein, 25 mM MgCl 2 , 500 M ATP, 10 Ci of [␥-32 P]ATP, and 1 g of a catalytically inactive form of JNK recombinant protein (Upstate Biotechnology Inc.) were added, and the reaction mixture was incubated for 30 min at 30°C. Reactions were stopped and phosphorylated proteins resolved by SDS-PAGE.
RESULTS AND DISCUSSION
Molecular Cloning of MAPKKK5-PCR was performed using degenerate oligonucleotide primers corresponding to the conserved regions of the catalytic domains of the yeast BYR2 and STE11 and mouse MEKK1. A PCR fragment containing novel sequences was amplified from a human spleen cDNA library and used to screen a human macrophage cDNA library by plaque hybridization to obtain full-length clones. Several overlapping fragments were isolated and sequenced. The nucleotide sequence of the combined cDNA sequences predicted an open reading frame of 1374 amino acids, which is preceded by an in-frame stop codon at the 5Ј end (Fig. 1) . The predicted initiator methionine is preceded by a purine at the Ϫ3 position and a purine at the ϩ4 position, making it optimal for translation initiation (36) . The predicted molecular mass for this protein is 154.54 kDa. A comparison of both nucleotide and amino acid sequences with the GenBank or EBI data bases found the MAPKKK5 sequences to be novel. The deduced amino acid sequence predicted a kinase catalytic domain between amino acids 671 and 914. The putative catalytic domain of the MAP-KKK5 shows 54.92% amino acid identity to the putative catalytic domain of the Drosophila melanogaster protein kinase PK92B (37) (the function of which is not known), 42.10% amino acid identity to the catalytic domain of the mouse MEKK2, 42.34% amino acid identity to the catalytic domain of mouse MEKK3, 41.53% amino acid identity to the catalytic domain of Schizosaccharomyces pombe BYR2, 41.78% amino acid identity to the catalytic domain of S. cerevisiae STE11, and 37.20% amino acid identity to the catalytic domain of the mouse MEKK1. The sequence alignment of the catalytic domain of MAPKKK5 with that of PK92B, MEKK1, -2, and -3 is shown in Fig. 2A . Apart from the catalytic domain, MAPKKK5 is quite different from the aforementioned kinases. Yeast MAPKKK, such as BYR2, STE11, BCK1, or mammalian MEKK1, -2, and -3 all have a kinase domain at the extreme C terminus (Fig.  2B) , while PK92B has a protein kinase domain near the N terminus. In contrast, the kinase domain of MAPKKK5 is located centrally between a 700-amino acid N-terminal domain and a 432-amino acid C-terminal domain. The N-and C-terminal domains of MAPKKK5 exhibit no significant homology to any sequences in the GenBank and EBI data bases.
Tissue Distribution of MAPKKK5 mRNA-The expression of the MAPKKK5 was examined in a variety of human tissues by Northern blot analysis. The MAPKKK5 probe hybridized to a single species of mRNA of approximately 6.5 kilobases (Fig. 3) . Among the tissues examined, strong hybridizing signals were observed in human heart and pancreas. Weaker signals were detected in human brain, placenta, lung, liver, and skeletal muscle (Fig. 3) . No signal was detected in kidney, even after prolonged exposure. 
Activation of JNK in Cells Transfected with MAPKKK5-The
significant homology between the catalytic domains of MAP-KKK5 and mouse MEKK2 and -3 suggested that MAPKKK5 may activate JNK and/or MAPK/ERK. To determine whether MAPKKK5 could activate JNK activity, COS cells were cotransfected with mammalian expression vectors encoding portions of MAPKKK5 and an HA epitope-tagged JNK. Recombinant JNK was then immunoprecipitated from cell lysates and used in a protein kinase assay with GST c-Jun protein as a substrate. As shown in Fig. 4 , transfection with two MAPKKK5 polypeptides resulted in strong activation of JNK (lanes 3 and  4) , while cells transfected with vector only had little effect (lane 2). The level of activation was comparable with that of cells stimulated with 10 ng/ml anisomycin (lane 5). Transfection with a kinase-inactive form of MAPKKK5, in which lysine 709 in the ATP binding domain was mutated to a glutamic acid, resulted in no activation of JNK (Fig. 4, lane 6) , indicating that the kinase activity of MAPKKK5 is required for the activation of JNK. Western blot analysis showed that the mutant was expressed at comparable levels with the wild type MAPKKK5 (data not shown).
MAPKKK5 Does Not Activate ERK2 in Transfected COS
Cells-To determine whether MAPKKK5 could also function to activate the ERK, COS cells were transiently transfected with MAPKKK5, along with flag epitope-tagged ERK2. ERK2 was then immunoprecipitated, and its activity was assayed in immunoprecipitates using Phas-I protein as a substrate. Addition of epidermal growth factor to COS cells strongly activated ERK2 (Fig. 5, lane 2) ; however, no increase in ERK2 activity was observed when MAPKKK5 polypeptides were overexpressed in COS cells (Fig. 5, lanes 4 and 5) . Western blot analysis confirmed that both MAPKKK5 and ERK2 were expressed in the transfected COS cells (data not shown). These data suggested that MAPKKK5 may not play a role in the classical MAPK/ERK pathway.
MAPKKK5 Phosphorylates and Activates MKK4 in Vitro-
The MEK level kinase that could serve as a substrate for MAPKKK5 in the JNK pathway is MKK4. To determine whether MAPKKK5 could phosphorylate MKK4 in vitro, 293 cells were transfected with flag epitope-tagged ⌬MAPKKK5 and ⌬MAPKKK5 were immunoprecipitated from cell lysates with M2 mAb and protein A-Sepharose. After extensive washing, the immunoprecipitated kinases were incubated with a catalytically inactive form of GST-MKK4 recombinant protein in the presence of [␥-
32 P]ATP. In repeated experiments, the MAPKKK5 phosphorylated a catalytically inactive form of MKK4 (Fig. 6, lane 3) , while immunoprecipitates from cells transfected with vector only or cells transfected with a kinaseinactive form of MAPKKK5 did not phosphorylate MKK4 in vitro (Fig. 6, lanes 2 and 4) . To determine whether MAPKKK5 could activate MKK4 in vitro, the immunoprecipitated kinases were incubated with GST-MKK4 recombinant protein and a kinase-inactive form of JNK. As shown in Fig. 6 , MAPKKK5 was able to phosphorylate MKK4. Phosphorylation of MKK4 was accompanied by an increase in the catalytic activity of GST-MKK4 as observed by the enhanced JNK phosphorylation in the coupled kinase reaction including MAPKKK5 (Fig. 6,  lane 7) . This result is consistent with the ability of MAPKKK5 to activate JNK in transfected COS cells in vivo. The kinaseinactive form of MAPKKK5 did not activate GST-MKK4 (lane 8). The 46-kDa phosphorylated bands observed were the autophosphorylated ⌬MAPKKK5 (Fig. 6, lanes 3 and 7) . The immunoprecipitated MAPKKK5 did not phosphorylate JNK when GST-MKK4 was omitted from the in vitro kinase assay (data not shown).
In summary, we have identified a new protein kinase with a catalytic domain related to yeast MAPKKK and mammalian MEKK but structurally distinct from the known MAPKKK.
Consistent with this finding, MAPKKK5 activated JNK but not the ERK pathway. In addition, MAPKKK5 phosphorylated and activated MKK4 in vitro. Further studies are needed to elucidate the upstream activators of MAPKKK5 and the physiological stimuli that activated MAPKKK5. The availability of the MAPKKK5 cDNA and recombinant protein will allow detailed studies of the mechanism of its action. 3 and 7) , or MAPKKK5 K709E mutant (lanes 4 and 8) were immunoprecipitated using M2 mAb and protein A-Sepharose. The immunoprecipitates were incubated with a kinase-inactive form of GST-MKK4 recombinant protein (lanes 2-4) or mouse GST-MKK4 plus a kinase-inactive form of GST-JNK recombinant proteins (lanes 6, 7, and 8). Lanes 1 and 5 were controls in which kinase reactions were performed in the absence of immunoprecipitates.
